Atason EZ 20/10 Tablet

Atason EZ 20/10 Tablet সম্পর্কে

বাংলাদেশে Atason EZ 20/10 Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Atorvastatin + Ezetimibe আছে (২০ mg + ১০ mg)। এটি তৈরি করে Advanced Chemical Industries PLC। Atason EZ 20/10-এর সাথে Atorvastatin + Ezetimibe-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Atorvastatin + Ezetimibe-এর ৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।

Atason EZ 20/10 Tablet কী?

Atason EZ 20/10 is a tablet containing atorvastatin and ezetimibe. Atorvastatin reduces cholesterol production in the liver and helps clear LDL cholesterol from the blood. Ezetimibe reduces the amount of cholesterol absorbed from the intestines. Together they help lower cholesterol levels when diet and exercise alone are not enough. This medicine is used as part of a wider plan to reduce the risk of heart and blood vessel problems linked to high cholesterol. It is available as a tablet with the strength 20 mg + 10 mg, manufactured by Advanced Chemical Industries PLC.

Atason EZ 20/10-এর ব্যবহার

Atason EZ 20/10 is used to lower high cholesterol levels in people who are at increased risk of heart and blood vessel disease. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures. The combination helps reduce LDL cholesterol and other fats in the blood. Your doctor will decide if this medicine is suitable for you based on your overall risk and health condition.

Atason EZ 20/10 কীভাবে ব্যবহার করবেন

Take Atason EZ 20/10 exactly as your doctor tells you. The dose and how often you take it are decided by your doctor based on your cholesterol levels and other health factors. Swallow the tablet whole with water. You can take it with or without food, but try to take it at the same time each day. Do not change the dose or stop taking it without talking to your doctor. If you miss a dose, ask your doctor or pharmacist what to do.

Atason EZ 20/10-এর পার্শ্বপ্রতিক্রিয়া

Like all medicines, Atason EZ 20/10 can cause side effects, although not everyone gets them. Some people may experience headache, stomach upset, muscle pain, or tiredness. Tell your doctor promptly if you notice unexplained or persistent muscle pain, tenderness, or weakness, as this can be a sign of a rare but serious muscle problem. Other side effects are possible. Ask your doctor or pharmacist for advice if you are worried about any symptoms.

সতর্কতা ও নিরাপত্তা

Do not take Atason EZ 20/10 if you have active liver disease or if you are pregnant or may become pregnant, or if you are breastfeeding. Tell your doctor if you have liver problems, thyroid problems, kidney problems, or if you drink a lot of alcohol. Also tell your doctor about all other medicines you take, as some can interact with this medicine. Your doctor may adjust your dose or monitor you more closely. Ask your doctor before starting any new medicine.

সাধারণ প্রশ্ন

What is Atason EZ 20/10 and what kind of medicine is it?

Atason EZ 20/10 is a tablet that combines two lipid-lowering medicines: atorvastatin and ezetimibe. It is used to lower cholesterol levels in the blood when diet and exercise alone are not enough. It belongs to a group of medicines called other lipid regulating drugs.

Who should avoid Atason EZ 20/10 or ask the doctor first?

Do not take this medicine if you are pregnant, may become pregnant, or are breastfeeding. Also avoid it if you have active liver disease or unexplained persistent liver enzyme elevations. Tell your doctor if you have kidney or thyroid problems, drink alcohol regularly, or take other medicines, as some can interact.

How should I take Atason EZ 20/10?

Take Atason EZ 20/10 exactly as prescribed by your doctor. The dose and duration are decided by your doctor based on your condition. Swallow the tablet whole with water and try to take it at the same time each day. Do not stop or change the dose without consulting your doctor.

What should I do if I miss a dose of Atason EZ 20/10?

If you miss a dose, ask your doctor or pharmacist for advice. Do not take a double dose to make up for a missed one. Follow your doctor's instructions about what to do if you forget a dose.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted ... Read moreTherapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.

Primary Hyperlipidemia: This tablet is indicated for the reduction of elevated total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and non-high-density lipoprotein cholesterol (non-HDL-C), and to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia.

Homozygous Familial Hypercholesterolemia (HoFH): This tablet is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Atorvastatin: In animal models, atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL; atorvastatin also reduces LDL production and the number of LDL particles.

Ezetimibe
: Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. The molecular target of ezetimibe has been shown to be the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is involved in the intestinal uptake of cholesterol and phytosterols. In a 2-week clinical study in 18 hypercholesterolemic patients, ezetimibe inhibited intestinal cholesterol absorption by 54%, compared with placebo. Ezetimibe had no clinically meaningful effect on the plasma concentrations of the fat-soluble vitamins A, D, and E and did not impair adrenocortical steroid hormone production. Ezetimibe does not inhibit cholesterol synthesis in the liver or increase bile acid excretion. Ezetimibe localizes at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver. This causes a reduction of hepatic cholesterol stores and an increase in clearance of cholesterol from the blood; this distinct mechanism is complementary to that of statins.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The dosage range is 10/10 mg/day through 80/10 mg/day. Recommended starting dose is 10/10 mg/day or 20/10 mg/day. Recommended starting dose is 40/10 mg/day for patients requiring a greater than 55% reduction in LDL-C.  Dosing of this tablet should occur either greater than or equal to 2 hours before or greater than or equal to 4 hours after administration of a bile acid sequestrant.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir), gemfibrozil: Avoid this tablet
  • HIV protease inhibitor (lopinavir plus ritonavir): Use with caution and lowest dose necessary.
  • Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir): Do not exceed 10/20 mg this tablet daily.
  • HIV protease inhibitor (nelfinavir), hepatitis C protease inhibitor (boceprevir): Do not exceed 10/40 mg this tablet daily.
  • Other lipid-lowering medications: Use with fenofibrates or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. Caution should be used when prescribing with this tablet.
  • Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid- lowering therapy should be considered.
  • Cholestyramine: Combination decreases exposure of ezetimibe.
  • Digoxin: Patients should be monitored appropriately.
  • Oral contraceptives: Values for norethindrone and ethinyl estradiol may be increased.
  • Rifampin should be simultaneously coadministered with this tablet.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Active liver disease or unexplained persistent elevations of hepatic transaminase levels.
  • Hypersensitivity to any component of this tablet.
  • Women who are pregnant or may become pregnant.
  • Nursing mothers.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category X. This tablet is contraindicated in women who are or may become pregnant. Serum cholesterol and triglycerides increase during normal pregnancy. Lipid-lowering drugs offer no benefit during pregnancy, because cholesterol and cholesterol derivatives are needed for normal fetal development. Atherosclerosis is a chronic process, and discontinuation of lipid-lowering drugs during pregnancy should have little impact on long-term outcomes of primary hypercholesterolemia therapy. It is not known whether atorvastatin is excreted in human milk, but a small amount of another drug in this class does pass into breast milk.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Patients should be advised to report promptly any unexplained and/or persistent muscle pain, tenderness, or weakness. This tablet should be discontinued immediately if myopathy is diagnosed or suspected.

Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with higher doses and concomitant use of certain CYP3A4 inhibitors, fibric acid derivatives, and cyclosporine. Predisposing factors include advanced age (>65), uncontrolled hypothyroidism, and renal impairment. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported.

Liver enzyme abnormalities: Persistent elevations in hepatic transaminase can occur. Check liver enzyme tests before initiating therapy and as clinically indicated thereafter.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Atorvastatin + Ezetimibe

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।